Pazopanib Hydrochloride
规格
635702-64-6CAS 号
619-728-0EC 号
5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide;hydrochlorideIUPAC 名称
C21H24ClN7O2S化学式
474 g/mol分子量
Pazopanib hydrochloride; 635702-64-6; pazopanib HCl; UNII-33Y9ANM545; pazopanib monohydrochloride; Pazopanib (as hydrochloride); 33Y9ANM545; 5-((4-((2,3-DIMETHYL-2H-INDAZOL-6-YL)(METHYL)AMINO)PYRIMIDIN-2-YL)AMINO)-2-METHYLBENZENESULFONAMIDE HYDROCHLORIDE; CHEBI:71217; DTXSID70212956; NSC737754; 5-((4-((2,3-Dimethyl-2H-indazol-6-yl)methylamino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide monohydrochloride; 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide hydrochloride; Benzenesulfonamide, 5-((4-((2,3-dimethyl-2H-indazol-6-yl)methylamino)-2-pyrimidinyl)amino)-2-methyl-, monohydrochloride; PAZOPANIB HYDROCHLORIDE (MART.); PAZOPANIB HYDROCHLORIDE [MART.]; 5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzenesulfonamide hydrochloride; 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide monohydrochloride; RefChem:55813; DTXCID00135447; 5-((4-((2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide monohydrochloride; Votrient; Pazopanib (Hydrochloride); Pazopanib HCl (GW786034 HCl); GW786034B; GW-786034B; MFCD12546138; GW786034 (Hydrochloride); 5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide;hydrochloride; S1035; GW 786034; Armala; 5-{4-[(2,3-Dimethyl-2H-indazol-6-yl)-methyl-amino]-pyrimidin-2-ylamino}-2-methyl-benzenesulfonamide hydrochloride; Patorma; GW786034 HCl; Votrient (TN); Pazopanib hydrochloride [USAN:JAN]; Pazopanib Hydrochloride?; C21H24ClN7O2S; MLS004774147; Pazopanib, Hydrochloride Salt; SCHEMBL159487; orb1224395; orb1300336; Pazopanib Hydrochloride [USAN]; CHEMBL1201733; SCHEMBL29386934; EX-A956; MQHIQUBXFFAOMK-UHFFFAOYSA-N; Pazopanib HCl (GW786034 ); GLXC-90208; HMS5079O05; Pazopanib HCl - Bio-X trade mark; Pazopanib hydrochloride (JAN/USAN); PAZOPANIB HYDROCHLORIDE [MI]; EBC-67069; PAZOPANIB HYDROCHLORIDE [JAN]; AKOS015958593; CCG-269485; CS-0126; FD71644; GSK-786034; KS-1458; NSC-737754; PB31655; SB10367; PAZOPANIB HYDROCHLORIDE [WHO-DD]; AC-24726; BP166746; HY-12009; SMR003500790; P2243; PAZOPANIB HYDROCHLORIDE [ORANGE BOOK]; SW218082-2; D05380; F519777; Q27888072; 5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]-2-pyrimidinyl}amino)-2-methylbenzenesulfonamide Hydrochloride; 5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzene-1-sulfonamide hydrochloride; 5-({4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzene-1-sulfonamide--hydrogen chloride (1/1); 5-[[4-[(2,3-dimethylindazol-6-yl)-methyl-amino]pyrimidin-2-yl]amino]-2-methyl-benzenesulfonamide;hydrochloride; 5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide hydrochloride; Benzenesulfonamide, 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-, hydrochloride (1:1)同义词
含有Pazopanib Hydrochloride的产品
보트리엔트정200밀리그램(파조파닙염산염)보트리엔트정400밀리그램(파조파닙염산염)ヴォトリエント錠200mgPAZOPANIB STADA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGPAZOPANIB STADA 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGPAZOPANIB GLENMARK 400 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFGPAZOPANIB GLENMARK 200 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFGPAZOPANIB ACCORD 400 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFGPAZOPANIB ACCORD 200 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFGVOTRIENT 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULAVOTRIENT 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULAPAZOPANIB DR. REDDYS 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
第 1/5 页
销售Pazopanib Hydrochloride的公司
AP
Aurobindo Pharma LimitedIndiaDR
Dr. Reddy's LaboratoriesIndiaML
MSN LaboratoriesIndiaCI
CiplaIndiaHR
Hangzhou Royall Import & Export Co.,LtdChinaSD
SHIJIAZHUANG DINGMIN PHARMACEUTICAL SCIENCES CO., LTDChinaWH
Wuxi Hexia Chemical CompanyChinaFL
Formosa Laboratories,INCTaiwan第 1/4 页